Zymeworks
ZYME
$8.76
Share price
2.10%
Change (1 day)
3.91%
Change (1 year)
Categories
Operating Margin for Zymeworks (ZYME)
Operating Margin as of May 2024 (TTM): 41.33%
According to Zymeworks's latest financial reports and stock price the company's current Operating Margin is 41.33%. At the end of 2021 the company had an Operating Margin of -795.95%.
Operating Margin history for Zymeworks from 2016 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -795.95% | 72.12% |
| 2020 | -462.43% | -6.44% |
| 2019 | -494.24% | 662.08% |
| 2018 | -64.85% | 236.98% |
| 2017 | -19.25% | -94.55% |
| 2016 | -353.20% | 78.3% |
| 2015 | -198.10% | -74.44% |
| 2014 | -774.97% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.